ZORYVE
NDC 80610-430, roflumilast, aerosol, foam, from Arcutis Biotherapeutics, Inc..
- Product NDC
- 80610-430
- Status
- Listed
- Labeler
- Arcutis Biotherapeutics, Inc.
- Dosage form
- AEROSOL, FOAM
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA217242
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/80610-430 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ROFLUMILAST3 mg/g
Pharmacologic classes
Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 80610-430-60 | 80610043060 | 1 CAN in 1 CARTON (80610-430-60) / 60 g in 1 CAN |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f9e0b4a9-a227-4947-b00c-41fb18d16589NADAC price for package 80610043060
GET /v1/drugs/nadac/80610043060
Use it
Look up 80610-430 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/80610-430 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 80610-430. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.